External validation of the Rotterdam Prostate Cancer Risk Calculator (RPCRC) and comparison to Stockholm3 for prostate cancer diagnosis in a Swedish population-based screening cohort

EUROPEAN UROLOGY(2023)

引用 0|浏览3
暂无评分
摘要
The use of the Rotterdam Prostate Cancer Risk Calculator available online to predict the risk of prostate cancer in a Swedish cohort was shown to be clinically harmful as it underpredicted the risk of clinically significant prostate cancer, while the Stockholm3 test performed well showed clinical benefits.
更多
查看译文
关键词
Prostate cancer diagnosis,Prostate cancer screening,Prostate-specific antigen,Risk calculator,Stockholm3
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要